MTOR and neoplasm: Consistent with suppression of tumour glycolysis, activation of phosphatidylinositol-3-kinase (PI3K), AKT and mammalian target of rapamycin (mTOR) in CRC tumours was also markedly inhibited by cold exposure (Fig. 4e,f).